Federal Circuit Affirms Prosecution Laches Defense Against Hyatt’s Decades-Old Patent Applications

Hyatt v. Stewart Authored by: Jeremy J. Gustrowsky In the long-running legal saga of inventor Gilbert P. Hyatt, the Federal Circuit has once again sided with the U.S. Patent and Trademark Office (USPTO), affirming that prosecution laches—a defense based on…

Read More

Federal Circuit Reins in Presidential Tariff Powers Under IEEPA

V.O.S. Selections, Inc. v. Trump Authored by: Jeremy J. Gustrowsky In a landmark decision, the Federal Circuit has ruled that the President does not have unlimited authority to impose tariffs under the International Emergency Economic Powers Act (IEEPA). The case,…

Read More

Who Can Challenge Federal Contracts? Federal Circuit Clarifies “Interested Party” Rule in Percipient.Ai v. United States

Percipient.Ai, Inc. v. United States Authored by: Jeremy J. Gustrowsky In a major decision for government contractors and tech companies, the Federal Circuit recently clarified who has the right to challenge federal procurement decisions in Percipient.Ai, Inc. v. United States…

Read More

Court Opens Door for Subcontractors to Challenge Federal Procurement Decisions

Percipient.ai, Inc. v. United States Authored by: Jeremy J. Gustrowsky A recent decision from the Federal Circuit could reshape who gets to challenge federal procurement decisions, especially when it comes to the use of commercial products and services in government…

Read More

Who Really Invented the Ointment? Federal Circuit Clarifies AIA Derivation Proceedings in Global Health Solutions v. Selner

Glob. Health Sols. LLC v. Selner Authored by: Jeremy J. Gustrowsky In a significant decision for patent law, the Federal Circuit in Global Health Solutions LLC v. Selner (148 F.4th 1363, decided August 26, 2025) clarified how derivation proceedings work…

Read More

Federal Circuit Reverses $4.7 Million DNA Patent Verdict, Clarifies “Identical” in Patent Claims

Lab’y Corp. of Am. Holdings v. Qiagen Sciences, LLC Authored by: Jeremy J. Gustrowsky In a significant decision for the biotech and patent law communities, the Federal Circuit has reversed a $4.7 million jury verdict against Qiagen Sciences, LLC, finding…

Read More

Federal Circuit Swiftly Dismisses Appeal Outside Its Patent Jurisdiction Wheelhouse

Allen v. Stein Authored by: Jeremy J. Gustrowsky In a quick ruling, the U.S. Court of Appeals for the Federal Circuit dismissed an appeal from a pro se litigant, highlighting the court’s narrow focus on patent and related matters rather…

Read More

Automated Dumbbells Get Their Day: Federal Circuit Clarifies Patent Eligibility for Fitness Tech

Powerblock Holdings, Inc. v. IFit, Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit reversed a lower court and ruled that PowerBlock Holdings, Inc.’s patent for automated dumbbells is eligible for patent protection. The case, PowerBlock…

Read More

Federal Circuit Strikes Down Mondis Patent for Lack of Written Description

Mondis Tech. Ltd. v. LG Elecs. Inc Authored by: Jeremy J. Gustrowsky In a significant decision for patent law, the Federal Circuit Court of Appeals reversed a $14.3 million damages award against LG Electronics, holding that key claims of U.S.…

Read More

Patent Owner’s Deletion of “Stability” Limits Claim Scope in Insecticide Patent Dispute

FMC Corp. v. Sharda USA, LLC Authored by: Jeremy J. Gustrowsky In FMC Corp. v. Sharda USA, LLC, the Federal Circuit vacated a preliminary injunction that had barred Sharda from selling its insecticide product, finding that the lower court misinterpreted…

Read More

Federal Circuit Orders New Trial on LED Tube Lamp Patents After Exclusion of Key Evidence

Jiaxing Super Lighting Elec. Appliance, Co., v. CH Lighting Tech. Co Authored by: Jeremy J. Justrowsky In a significant patent dispute over LED tube lamp technology, the Federal Circuit has sent the case of Jiaxing Super Lighting Electric Appliance Co.,…

Read More

Federal Circuit Dodges Patent Royalty Battle, Transfers Case Over Jurisdiction Hiccup

Acorda Therapeutics, Inc. v. Alkermes PLC Authored by: Jeremy J. Gustrowsky In the world of pharmaceutical partnerships, Acorda Therapeutics and Alkermes PLC once teamed up to bring Ampyra—a drug helping multiple sclerosis patients walk better—to market. Alkermes held a key…

Read More